Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes-Reference-Cited by-同舟云学术

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes

Published:2015-12 Issue:22 Volume:132 Page:
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Maron Barry J.,Levine Benjamin D.,Washington Reginald L.,Baggish Aaron L.,Kovacs Richard J.,Maron Martin S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000238

Reference39 articles.

1. Assessment of the 12-Lead ECG as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age)

2. Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update

3. Cardiovascular Preparticipation Screening of Competitive Athletes

4. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations Revisited

5. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-participation evaluation of recreational and competitive athletes – A systematic review of guidelines and consensus statements;2024-03-25

2. Can we screen for heart disease in children at public health centres? A multicentre observational study of screening for heart disease with a risk of sudden death in children;European Journal of Pediatrics;2024-03-08

3. Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis;Science China Life Sciences;2024-02-07

4. Posicionamiento mexicano para el tamizaje y la evaluación cardiovascular preparticipación deportiva;Archivos de Cardiología de México;2023-12-22

5. Can we Screen for Heart Disease with a Risk of Sudden Death in Children at Public Health Centres? The ECIAP (Evaluación Cardiovascular Infantil en Atención Primaria) Study: Cardiovascular Assessment in Children in Primary Care. A multicentre observational study of screening for heart disease with a risk of sudden death.;2023-12-13